MIR1258: A Drug Target / Disease Biomarker (G100302172)

MIR1258: A Drug Target / Disease Biomarker

MIR1258 is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the miRNA-protein complex, which plays a critical role in regulating gene expression. The miRNA-protein complex consists of a protein that acts as a scaffold to recruit other proteins to the target gene. MIR1258 is one of these proteins, and it is involved in the regulation of many different genes.

One of the things that makes MIR1258 so interesting as a drug target is its role in the regulation of cell death. Cell death, also known as apoptosis, is a natural process that helps the body remove damaged or unnecessary cells. When a cell is no longer needed or is no longer functioning properly, it can trigger an apoptosis cascade that results in the cell being killed and the body trying to remove the dead cell.

MIR1258 is involved in the regulation of cell death by promoting the formation of apoptotic cells. This is done by recruiting other proteins that are involved in the regulation of cell death, such as Bax. Bax is a protein that is known to play a key role in the regulation of cell death. When Bax is recruited to a cell, it can trigger the formation of an apoptotic cascade.

MIR1258 is also involved in the regulation of cell growth. Cell growth is the process by which cells increase in size and complexity. This is important for the development and maintenance of tissues in the body. MIR1258 is involved in the regulation of cell growth by recruiting other proteins that promote cell growth, such as S6. S6 is a protein that is known to play a key role in the regulation of cell growth.

MIR1258 is also involved in the regulation of cell signaling. Signal transduction is the process by which cells respond to signals from the environment. This is important for the regulation of many different cellular processes, including cell growth and cell death. MIR1258 is involved in the regulation of cell signaling by recruiting other proteins that are involved in signal transduction, such as phosphatidylinositol 3-kinase (PI3K).

MIR1258 is also involved in the regulation of cell adhesion. Cell adhesion is the process by which cells stick together to form tissues. This is important for the development and maintenance of tissues in the body. MIR1258 is involved in the regulation of cell adhesion by recruiting other proteins that are involved in cell adhesion, such as cadherin.

MIR1258 is also involved in the regulation of inflammation. Inflammation is a natural response of the body to injury or infection. It is important for the regulation of inflammation by recruiting other proteins that are involved in inflammation, such as nuclear factor kappa B (NFKB).

MIR1258 is also involved in the regulation of cellular processes that are important for the development and maintenance of tissues in the body. This includes the regulation of cell cycle progression, the regulation of DNA replication, and the regulation of cell signaling.

MIR1258 is a protein that is involved in many different cellular processes that are important for the development and maintenance of tissues in the body. As a drug target, MIR1258 may be useful in the treatment of a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Protein Name: MicroRNA 1258

The "MIR1258 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1258 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143